Issues of the country's drug safety were discussed in the State Duma with the participation of Promomed Group of Companies

A round table "Topical issues of import substitution of medicines" was held in the State Duma under the chairmanship of Fedot Tumusov, First Deputy Chairman of the State Duma Committee on Health Protection. It was attended by representatives of relevant ministries and departments, deputies of the State Duma, experts in the field of healthcare, representatives of the professional medical community. Promomed Group was represented by Dmitry Zemskov, Director of Investment Activities.

Dmitry Zemskov noted the importance of localizing the production of substances in the country. Promomed has taken another step towards strengthening the country's drug sovereignty. In March, with the participation of Russian President Vladimir Putin, a plant for the production of active pharmaceutical substances with a capacity of 340 tons per year was opened. These are substances for the manufacture of medicines of almost all therapeutic groups, primarily for the treatment of socially significant diseases. The speaker shared the practice of multi-stage cooperation between an industrial partner and a scientific center. An example of such interaction is the Ogarev Mordovian State University. The result of fruitful work was the Department of Chemistry and Technology of Physiologically active Substances, open laboratories. Joint educational programs, research activities, and projects for the joint development and conduct of clinical and preclinical research are being successfully implemented.

The meeting discussed measures of state support for Russian pharmaceutical enterprises and the need to improve legislation in this area, and touched upon the export of Russian medicines. The participants of the round table also paid attention to the issues of safety, control and examination of medicines entering the market, technological sovereignty and export to open markets.

Information about the event on the SRP website.